Christine S. Rollier

• The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.

  Diemen PMV. et al, (2017), Sci Rep, 7, 1745 - 1745

• Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci.

  Giuntini S. et al, (2017), Clin Vaccine Immunol, 24

• Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.

  Rollier CS. et al, (2016), Vaccine

• Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion.

  Whitehouse J. et al, (2016), Vaccine, 34, 1792 - 1799

• Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.

  Daniels-Treffandier H. et al, (2016), PLoS One, 11

• A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.

  Marsay L. et al, (2015), J Infect, 71, 326 - 337

• Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles.

  Weissmueller NT. et al, (2015), Clin Vaccine Immunol, 22, 586 - 592

• The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.

  Rollier CS. et al, (2015), Expert Opin Biol Ther, 15, 131 - 142

• A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial

  Marsay L. et al, (2015), Journal of Infection, 71, 326 - 337

• Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.

  Nagaputra JC. et al, (2014), Clin Vaccine Immunol, 21, 234 - 242

• Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.

  Mehta OH. et al, (2014), PLoS One, 9

• Irradiated wild-type and Spa mutant Staphylococcus aureus induce anti-S. aureus immune responses in mice which do not protect against subsequent intravenous challenge.

  van Diemen PM. et al, (2013), Pathog Dis, 68, 20 - 26

• Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity

  Reyes-Sandoval A. et al, (2012), Molecular Therapy, 20, 1633 - 1647

• Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.

  Reyes-Sandoval A. et al, (2012), Mol Ther, 20, 1633 - 1647

• Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.

  Spencer AJ. et al, (2012), PLoS One, 7

• Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.

  Verstrepen BE. et al, (2011), J Infect Dis, 204, 837 - 844

• CD8+ T effector memory cells protect against liver-stage malaria

  Reyes-Sandoval A. et al, (2011), Journal of Immunology, 187, 1347 - 1357

• Viral vectors as vaccine platforms: Deployment in sight

  Rollier CS. et al, (2011), Current Opinion in Immunology, 23, 377 - 382

• Viral vectors as vaccine platforms: deployment in sight.

  Rollier CS. et al, (2011), Curr Opin Immunol, 23, 377 - 382

• Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates

  Capone S. et al, (2010), Vaccine, 29, 256 - 265

• CD8(+) T effector memory cells are a correlate of protection against liver-stage malaria

  Reyes-Sandoval A. et al, (2010), IMMUNOLOGY, 131, 158 - 159

• Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.

  Alcock R. et al, (2010), Sci Transl Med, 2

• Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines.

  Larsen KC. et al, (2009), Vaccine, 27, 5589 - 5598

• Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates

  Verstrepen BE. et al, (2008), Vaccine, 26, 3346 - 3351

• New vectored vaccines for malaria.

  Hill AVS. et al, (2008), INTERNATIONAL JOURNAL FOR PARASITOLOGY, 38, S32 - S32

• Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

  Larrea E. et al, (2007), J Virol, 81, 3662 - 3666

• Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.

  Rollier CS. et al, (2007), Hepatology, 45, 602 - 613

• Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting.

  Rollier C. et al, (2005), J Infect Dis, 192, 920 - 929

• Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.

  Thermet A. et al, (2004), J Virol, 78, 1945 - 1953

• Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.

  Rollier C. et al, (2004), J Virol, 78, 187 - 196

• Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment.

  Rollier C. et al, (2003), Hepatology, 38, 851 - 858

• Progress in DNA vaccine for prophylaxis and therapy of hepatitis B.

  Thermet A. et al, (2003), Vaccine, 21, 659 - 662

• Vaccination of chimpanzees with a multicomponent DNA-protein prime-boost regimen provides an enhanced recovery following heterologous HCV challenge.

  Heeney J. et al, (2001), HEPATOLOGY, 34, 450A - 450A

• DNA immunization for identification and localization of antigenic regions on duck hepatitis B virus core protein.

  Thermet A. et al, (2001), HEPATOLOGY, 34, 322A - 322A

• Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein.

  Rollier C. et al, (2000), Vaccine, 18, 3091 - 3096

• Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection.

  Rollier C. et al, (2000), J Virol, 74, 4908 - 4911

• DNA immunization for production in egg factory of protective antibodies against hepadnavirus infection

  Rollier C. et al, (1999), HEPATOLOGY, 30, 300A - 300A

• Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction.

  Sunyach C. et al, (1999), J Virol, 73, 2569 - 2575

• Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

  Rollier C. et al, (1999), Gastroenterology, 116, 658 - 665

• Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

  Rollier C. et al, (1998), HEPATOLOGY, 28, 319A - 319A

• Viral vectors as vaccine platforms: from immunogenicity to impact

  Ewer (nee Russell) KJ. et al, Current Opinion in Immunology

• T and B cell Responses to Multivalent Prime-Boost DNA and Viral Vectors Vaccine Combinations against Hepatitis C Virus in Non-Human Primates

  Rollier CS., Gene Therapy (Basingstoke)

• Naturally mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formation

  Sinclair-Van Diemen PM. et al, PNAS

• MRI based quantification of abscesses following experimental S. aureus intravenous challenge: application to vaccine evaluation.

  Van Diemen PM. et al, PLoS One

Recent Publications

• The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.

  Diemen PMV. et al, (2017), Sci Rep, 7, 1745 - 1745

• Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci.

  Giuntini S. et al, (2017), Clin Vaccine Immunol, 24

• Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.

  Rollier CS. et al, (2016), Vaccine

• Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion.

  Whitehouse J. et al, (2016), Vaccine, 34, 1792 - 1799

• Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.

  Daniels-Treffandier H. et al, (2016), PLoS One, 11